Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Re-treatment Strategies after Stopping Nucleos(t)ide Analogues in HBeAg-negative and Non-cirrhotic Chronic Hepatitis B Patients
TCTR20240818004Phase 4Not yet recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Nov 2024
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in Chronic Hepatitis B (CHB), sponsored by Faculty of Medicine, Chulalongkorn University. Planned start Nov 2024; status: not yet recruiting.
02
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on TCTR20240818004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240818004.